Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial

We previously demonstrated the safety and feasibility of mesenchymal stem cell (MSC) transplantation for bronchopulmonary dysplasia (BPD) in preterm infants in a phase I clinical trial. We thus investigated the therapeutic efficacy of MSCs for BPD in premature infants. A phase II double‐blind, rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, So Yoon, Chang, Yun Sil, Lee, Myung Hee, Sung, Se In, Lee, Byong Sop, Kim, Ki Soo, Kim, Ai‐Rhan, Park, Won Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284779/
https://www.ncbi.nlm.nih.gov/pubmed/33876883
http://dx.doi.org/10.1002/sctm.20-0330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284779/
https://www.ncbi.nlm.nih.gov/pubmed/33876883
http://dx.doi.org/10.1002/sctm.20-0330

Ejemplares similares